Feedback Plc #FDBK – Trevor Brown shareholding

TR-1: Standard form for notification of major holdings 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: Feedback plc 1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate) Non-UK issuer 2. Reason for the notification (please mark the appropriate box […]

Feedback #FDBK – Trevor Brown shareholding

TR-1: Standard form for notification of major holdings 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii: Feedback plc 1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate) Non-UK issuer 2. Reason for the notification (please mark the appropriate box […]

Feedback #FDBK – Appointment of Chief Financial Officer

Feedback plc (AIM: FDBK), the specialist medical imaging technology company, announces that it has appointed Lindsay Melvin as Chief Financial Officer and a director of Feedback with immediate effect. Mr Melvin is a chartered accountant and brings 30 years of financial and business experience to Feedback.  Most recently he was Chief Executive Officer of the […]

Feedback #FDBK – Interim Report for the six months ended 30 November 2017

Cambridge, UK – 26 February 2018: Feedback plc (AIM: FDBK), the specialist medical imaging technology company, announces its unaudited results for the six months ended 30 November 2017.  Operational highlights (including post-period end)1 ·      Exclusive TexRAD® distributor agreements signed in China and Korea ·      CE marked release of TexRAD® Lung ·      Three pilot TexRAD® Lung installations secured with existing research customers ·      Significant TexRAD® research […]

Feedback #FDBK – Appointment of new CEO to drive growth strategy

Feedback plc (AIM: FDBK), the specialist medical imaging technology company, announces that it has appointed David Crabb as Chief Executive Officer and a director of Feedback with immediate effect.  This appointment will underpin the execution of the Company’s growth strategy following the first CE marked release of TexRAD®; the Company’s patented quantitative image texture analysis […]